MedCity News Sponsored Webinar On-Demand

Accelerate time to target endpoint in Cardiometabolic studies using patient-centered technology solutions

In this webinar, industry experts from Syneos and Medable share their perspectives on how to address the drug development challenges slowing cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.

Attendees will learn how to leverage technology and home health solutions to augment existing points of care between patients and their clinical care team in order to improve the patient experience, drive better data, and achieve timely endpoint capture.

Key learning objectives for this webinar include:

  • Best practices in the use of digital and home health solutions to solve for key delivery pain points in cardiometabolic trials (including wearables/sensors/connected devices)
  • How to leverage technology to achieve better patient representation in trials to meet the requirement of new DEI regulatory guidance
  • How to accelerate time to target endpoint while improving the patient experience using best-in-class digital solutions

Who should attend:

  • Clinical operations / development professionals
  • Cardiometabolic TA lead professionals
  • R&D IT / technology professionals
  • Chief Diversity Officers (DEI related roles)
  • Chief Medical Officers / Chief Scientific Officers
  • Clinical trial strategy team professionals

Watch On-Demand

Cardiometabolic Clinical Studies

Learn how to combat these, and more, with this free webinar featuring industry experts from Syneos and Medable. Together, they’ll share how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.
Our speakers:

Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.

MaryAnne Rizk is a Chief Strategy Officer at Medable.

Tammy D'Lugin-Monroe is a Vice President, Global Head Therapeutic Strategy Innovation at Syneos Health.

Decoration

Cardiometabolic Clinical Studies

Learn how to combat these, and more, with this free webinar featuring industry experts from Syneos and Medable. Together, they’ll share how to address these challenges, while also identifying how trials will change as a result of new regulatory guidance such as the DEPICT Act.
Our speakers:

Claire Marsden is a Vice President of DCT Solutions, CV/MET at Medable.

MaryAnne Rizk is a Chief Strategy Officer at Medable.

Tammy D'Lugin-Monroe is a Vice President, Global Head Therapeutic Strategy Innovation at Syneos Health.